{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:57Z","timestamp":1790959137193,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Foot"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.foot.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:59:19Z","timestamp":1552568359000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["The impact of topical phenytoin loaded nanostructured lipid carriers in diabetic foot ulceration"],"prefix":"10.1016","volume":"40","author":[{"given":"Amira","family":"Motawea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd El-Gawad H.","family":"Abd El-Gawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaa","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-6877","authenticated-orcid":false,"given":"Mohamad","family":"Motawea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Tarshoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.foot.2019.03.007_bib0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14728214.11.4.709","article-title":"Emerging drugs for diabetic foot ulcers","volume":"11","author":"Petrova","year":"2006","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.foot.2019.03.007_bib0010","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/S0002-9610(03)00297-6","article-title":"Pressure and the diabetic foot: clinical science and offloading techniques","volume":"187","author":"Boulton","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.foot.2019.03.007_bib0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1524-475X.2005.00075.x","article-title":"Plantar pressurein off-loading devices used in diabetic ulcer treatment","volume":"13","author":"Beuker","year":"2005","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.foot.2019.03.007_bib0020","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1086\/383270","article-title":"Wound dressings in diabetic foot disease","volume":"1","author":"Hilton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.foot.2019.03.007_bib0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/wound.2015.0635","article-title":"Challenges in the treatment of chronic wounds","volume":"4","author":"Frykberg","year":"2015","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.foot.2019.03.007_bib0030","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3109\/10717544.2013.873837","article-title":"Nonionic surfactant-based vesicular system for transdermal drug delivery","volume":"22","author":"Ghanbarzadeh","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.foot.2019.03.007_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0975-1483.62215","article-title":"Evaluation of wound healing effect of topical phenytoin on excisional wound in albino rats","volume":"2","author":"Hasamnis","year":"2010","journal-title":"J Young Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/147323000403200213","article-title":"Phenytoin-induced lymphocytic chemotaxis, angiogenesis and accelerated healing of decubitus ulcer in a patient with stroke","volume":"32","author":"Pitiakoudis","year":"2004","journal-title":"J Int Med Res"},{"key":"10.1016\/j.foot.2019.03.007_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2230.2008.02789.x","article-title":"A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa","volume":"34","author":"Langan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.foot.2019.03.007_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/jowc.2009.18.1.32146","article-title":"The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration","volume":"18","author":"El-Nahas","year":"2009","journal-title":"J Wound Care"},{"key":"10.1016\/j.foot.2019.03.007_bib0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijsu.2011.02.007","article-title":"The use of topical phenytoin for healing of chronic venous ulcerations","volume":"9","author":"Hokkam","year":"2011","journal-title":"Int J Surg"},{"key":"10.1016\/j.foot.2019.03.007_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S0080-623420140000100021","article-title":"Scientific production on the applicability of phenytoin in wound healing","volume":"48","author":"Firmino","year":"2014","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.foot.2019.03.007_bib0065","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1021\/acsami.6b04369","article-title":"Single-dose electrospun nanoparticles-in-nanofibers wound dressings with enhanced epithelialization, collagen deposition and granulation properties","volume":"8","author":"Ali","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.foot.2019.03.007_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.07.032","article-title":"Topical Amphotericin B solid lipid nanoparticles: design and development","volume":"139","author":"Butani","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.foot.2019.03.007_bib0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2014.10.029","article-title":"Oil-enriched, ultra-small nanostructured lipid carriers (usNLC): a novel delivery system based on flip-flop structure","volume":"477","author":"Keck","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chemphyslip.2014.11.004","article-title":"Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis","volume":"186","author":"Pradhan","year":"2015","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.foot.2019.03.007_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.15171\/apb.2015.022","article-title":"Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs","volume":"5","author":"Ezzati Nazhad Dolatabadi","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.foot.2019.03.007_bib0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/03639045.2015.1062896","article-title":"Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia","volume":"42","author":"Hamishehkar","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","article-title":"Nanoparticles and microparticles for skin drug delivery","volume":"63","author":"Prow","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.foot.2019.03.007_bib0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/03639040600814676","article-title":"Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of Valdecoxib","volume":"32","author":"Joshi","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijpharm.2015.09.054","article-title":"Tadalafil-loaded nanostructured lipid carriers using permeation enhancers","volume":"495","author":"Baek","year":"2015","journal-title":"Inter J Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0110","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2147\/IJN.S45313","article-title":"Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect","volume":"8","author":"Rahman","year":"2013","journal-title":"Inter J Nanomedicine"},{"key":"10.1016\/j.foot.2019.03.007_bib0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2006.12.043","article-title":"Formulation and characterization of curcuminoids loaded solid lipid nanoparticles","volume":"337","author":"Tiyaboonchai","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1049\/iet-nbt.2014.0030","article-title":"Drug release, cell adhesion and wound healing evaluations of electrospun carboxymethyl chitosan\/polyethylene oxide nanofibres containing phenytoin sodium and vitamin C","volume":"9","author":"Zarandi","year":"2015","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.foot.2019.03.007_bib0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D30Z3612W1","article-title":"Topical phenytoin for wound healing","volume":"10","author":"Bhatia","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.foot.2019.03.007_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-4362.1993.tb02799.x","article-title":"Topical phenytoin in wound healing","volume":"32","author":"Pendse","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.foot.2019.03.007_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-10-7","article-title":"Assessment of the effect of phenytoin on cutaneous healing from excision of melanocytic nevi on the face and on the back","volume":"10","author":"Pereira","year":"2010","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.foot.2019.03.007_bib0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejpb.2009.12.008","article-title":"Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics","volume":"74","author":"Chen","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.foot.2019.03.007_bib0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1208\/s12249-011-9727-6","article-title":"Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design","volume":"13","author":"Patel","year":"2012","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.foot.2019.03.007_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.foot.2019.03.007_bib0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.colsurfb.2013.06.032","article-title":"Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumor activity, cellular uptake and improved in vivo bioavailability","volume":"111","author":"Sun","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.foot.2019.03.007_bib0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/10837450.2013.778872","article-title":"Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam","volume":"19","author":"Khalil","year":"2014","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.foot.2019.03.007_bib0165","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4314\/tjpr.v13i5.1","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: physicochemical stability and drug penetration through rat skin","volume":"13","author":"Uner","year":"2014","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.foot.2019.03.007_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jsps.2012.11.005","article-title":"Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia","volume":"21","author":"Uprit","year":"2013","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.foot.2019.03.007_bib0175","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2133.2007.08160.x","article-title":"The clinical effect of topical phenytoin on wound healing: a systematic review","volume":"157","author":"Shaw","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.foot.2019.03.007_bib0180","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.colsurfb.2015.10.041","article-title":"Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles","volume":"136","author":"Ghanbarzadeh","year":"2015","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["The Foot"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259218300841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958259218300841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:27:26Z","timestamp":1760693246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958259218300841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":36,"alternative-id":["S0958259218300841"],"URL":"https:\/\/doi.org\/10.1016\/j.foot.2019.03.007","relation":{},"ISSN":["0958-2592"],"issn-type":[{"value":"0958-2592","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of topical phenytoin loaded nanostructured lipid carriers in diabetic foot ulceration","name":"articletitle","label":"Article Title"},{"value":"The Foot","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.foot.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}